{"title": "BRIEF-Clearside Biomedical announces first patient randomized in phase 2 clinical trial of CLS-TA", "author": "Reuters Staff", "url": "https://www.reuters.com/article/brief-clearside-biomedical-announces-fir-idUKASA09WQF", "hostname": "reuters.com", "description": "* Clearside Biomedical announces first patient randomized in phase 2 clinical trial of cls-ta used together with eylea in patients with diabetic macular edema", "sitename": "Reuters", "date": "2017-07-11", "cleaned_text": "expect to report three-month preliminary data in first half of 2018 Source text for Eikon: Further company coverage: "}